Annals ofOncology

Volume: 5 - Number: 39 - April 15, 2005

Outstanding

Glioma Therapies: How to Tell Which Work?

Undertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly Women

The Addition of Interleukin-6 Soluble Receptor and Transforming Growth Factor Beta1 Improves a Preoperative Nomogram for Predicting Biochemical Progression in Patients With Clinically Localized Prostate Cancer

Analysis of Surgical Salvage After Failure of Primary Therapy in Rectal Cancer: Results From Intergroup Study 0114

ART OF ONCOLOGY

Run for Your Life: The Reaction of Some Professionals to a Person With Cancer

Breast Cancer

Undertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly Women

Inherited and Acquired Risk Factors for Venous Thromboembolic Disease Among Women Taking Tamoxifen to Prevent Breast Cancer

High p27Kip1 Expression Predicts Superior Relapse-Free and Overall Survival for Premenopausal Women With Early-Stage Breast Cancer Receiving Adjuvant Treatment With Tamoxifen Plus Goserelin

DIAGNOSIS IN ONCOLOGY

Diagnostic Challenges in Patients With Tumors: CASE 1. GOSSYPIBOMA (FOREIGN BODY) MANIFESTING 30 YEARS AFTER LAPAROTOMY

Diagnostic Challenges in Patients With Tumors: CASE 2. STAPHYLOCOCCAL SCALDED-SKIN SYNDROME IN A PATIENT WITH EXTENDED SMALL-CELL LUNG CANCER

Diagnostic Challenges in Patients With Tumors: CASE 3. NORMAL-SIZED OVARIAN CANCER DETECTED BY COLOR DOPPLER ULTRASOUND USING A MICROBUBBLE CONTRAST AGENT

Editorial

Glioma Therapies: How to Tell Which Work?

Advances in Molecular Staging of Melanoma Patients: Multimarker Analysis of Archival Lymph Node Tissue

The Ingredients for Prostate Cancer Nomograms: The Addition of Biomarkers Sets the Table for Future Recipes

What Constitutes Optimal Care for Older Women With Breast Cancer?

The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or Sensitivity

Genitourinary Cancer

The Addition of Interleukin-6 Soluble Receptor and Transforming Growth Factor Beta1 Improves a Preoperative Nomogram for Predicting Biochemical Progression in Patients With Clinically Localized Prostate Cancer

Melanoma

Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph Nodes

ORIGINAL REPORTS Central Nervous System

Thallium-201 Single-Photon Emission Computed Tomography As an Early Predictor of Outcome in Recurrent Glioma

ORIGINAL REPORTS Gastrointestinal Cancer

Analysis of Surgical Salvage After Failure of Primary Therapy in Rectal Cancer: Results From Intergroup Study 0114

Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer

Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance

Postoperative Nomogram for Disease-Specific Survival After an R0 Resection for Gastric Carcinoma

Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer

ORIGINAL REPORTS Hematologic Malignancies

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymph

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

Pediatric Oncology

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

Review

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

SPECIAL ARTICLES

The Impact of a Physician Awareness Group and the First Year of Training on Hematology-Oncology Fellows

The Phase III Trial in the Era of Targeted Therapy: Unraveling the "Go or No Go" Decision

SUPPORTIVE CARE

Quality of Life in Women With Breast Cancer During the First Year After Random Assignment to Adjuvant Treatment With Marrow-Supported High-Dose Chemotherapy With Cyclophosphamide, Thiotepa, and Carboplatin or Tailored Therapy With Fluorouracil, Epirubicin